TABLE 1 Expression Levels of Oct2, Oct1, and BOB.1/OBF.1 in Lymphoid Tumors

From: Analysis of Octamer-Binding Transcription Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in Lymphomas

Lymphoid Tumor

N

Oct2

Oct1

BOB.1/OBF.1

  

+++

++

+

+++

++

+

+++

++

+

B-cell lymphoma

             

 B-cell chronic lymphocytic leukemia

2

1

1

0

0

0

2

0

0

0

2

0

0

 Mantle cell lymphoma

6

0

6

0

0

0

4

2

0

0

5

1

0

 Extranodal marginal zone B-cell lymphoma

5

3

2

0

0

3

2

0

0

4

1

0

0

 Nodal marginal zone B-cell lymphoma

4

3

1

0

0

4

0

0

0

0

4

0

0

 Splenic marginal zone B-cell lymphoma

6

3

3

0

0

0

4

2

0

1

5

0

0

 Follicular lymphoma

10

10

0

0

0

4

6

0

0

6

4

0

0

 Lymphoplasmacytic lymphoma

4

3

1

0

0

2

1

1

0

2

1

1

0

 Multiple myeloma

1

1

0

0

0

0

1

0

0

0

1

0

0

 Diffuse large B-cell lymphoma

47

33

10

2

2

9

29

9

0

22

23

2

0

 Burkitt’s lymphoma

10

10

0

0

0

10

0

0

0

10

0

0

0

Total

94

67

24

2

2

32

49

14

0

45

46

4

0

T-cell lymphoma

             

 Angioimmunoblastic T lymphoma

4

0

2

2

0

0

3

1

0

0

0

3

1

 Lymphoblastic T lymphoma

4

0

0

2

2

0

4

0

0

0

2

1

1

 Extranodal NK/T-cell lymphoma

2

0

1

0

1

0

1

1

0

0

0

0

2

 Peripheral T-cell lymphoma

5

0

2

1

2

0

4

1

0

0

0

5

0

 Anaplastic large T-cell lymphoma

2

0

0

1

1

0

1

1

0

0

0

2

0

Total

17

0

5

6

6

0

13

4

0

0

2

11

4

Hodgkin’s lymphoma

             

 Mixed cellularity Hodgkin’s lymphoma

12

4

5

1

2

1

6

5

0

0

5

3

4

 Nodular sclerosis Hodgkin’s lymphoma

8

0

1

3

4

0

3

4

1

0

1

5

2

 Lymphocyte depletion Hodgkin’s lymphoma

2

0

1

1

0

0

2

0

0

0

1

1

0

 Lymphocyte-rich classical Hodgkin’s lymphoma

2

0

0

1

1

0

2

0

0

0

1

0

1

 Lymphocyte-predominant Hodgkin’s lymphoma

5

5

0

0

0

3

2

0

0

1

4

0

0

Total

29

9

7

6

7

4

15

9

1

1

12

9

7